Perspectives for pharmaceutical screening at XFEL sources using the example of Lassa virus endonuclease

Falke, S.; Reinke, P.Y.A.; Rosenberg, D.; Fischer, P.; Meyer, J.; Galchenkova, M.; Tolstikova, A.; Mariani, V.; Senst, J.M.; Lewe, P.; Witt, S.; Wagner, A.; Chapman, H.N.; Hunter, M.; Günther, S.; Meents, A.

doi:10.1107/S2059798326009435

Figure 5
Isomorphous F_o(complex) − F_o(apo) maps defining the compound binding in the LASVendoN structures with (a) DPBA and (b) BXA. Maps are contoured at 3σ and shown within 3 Å of the compound and Mg²⁺ ions.

STRUCTURAL
BIOLOGY

ISSN: 2059-7983

Volume 82| Part 10| October 2026| Pages 1181-1194

https://doi.org/10.1107/S2059798326009435

Open

access